Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!
The proposed medication, from Bristol-Myers Squibb and Pfizer, prevents more strokes with less bleeding risk than existing treatment. It needs F.D.A. approval.
By THOM SHANKER and STEVEN LEE MYERS 24 Jun, 2011--
Source: http://feeds.nytimes.com/click.phdo?i=bc7fee1b31f6fbd8e15e5109b016ce5a
~
Manage subscription | Powered by rssforward.com